Viemed Healthcare, Inc. (NASDAQ:VMD) Director Randy E. Dobbs Sells 36,261 Shares

by · The Cerbat Gem

Viemed Healthcare, Inc. (NASDAQ:VMD – Get Free Report) Director Randy E. Dobbs sold 36,261 shares of Viemed Healthcare stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total value of $336,502.08. Following the sale, the director now owns 107,706 shares in the company, valued at $999,511.68. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Viemed Healthcare Stock Performance

NASDAQ:VMD traded down $0.25 during mid-day trading on Wednesday, reaching $9.15. 254,507 shares of the stock were exchanged, compared to its average volume of 154,050. The stock has a market capitalization of $356.30 million, a P/E ratio of 34.07 and a beta of 1.43. Viemed Healthcare, Inc. has a 1 year low of $6.21 and a 1 year high of $10.44. The company has a 50 day simple moving average of $8.28 and a 200-day simple moving average of $7.52. The company has a quick ratio of 1.19, a current ratio of 1.31 and a debt-to-equity ratio of 0.03.

Viemed Healthcare (NASDAQ:VMD – Get Free Report) last announced its earnings results on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The business had revenue of $58.00 million for the quarter.

Institutional Investors Weigh In On Viemed Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. increased its position in Viemed Healthcare by 53.0% in the 1st quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock valued at $16,803,000 after acquiring an additional 617,009 shares during the period. Kent Lake Capital LLC acquired a new position in shares of Viemed Healthcare in the first quarter valued at approximately $5,557,000. Penbrook Management LLC increased its holdings in shares of Viemed Healthcare by 236.0% in the second quarter. Penbrook Management LLC now owns 231,607 shares of the company’s stock valued at $1,517,000 after purchasing an additional 162,670 shares during the period. Apis Capital Advisors LLC raised its stake in shares of Viemed Healthcare by 193.0% during the second quarter. Apis Capital Advisors LLC now owns 234,400 shares of the company’s stock worth $1,535,000 after purchasing an additional 154,400 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its holdings in shares of Viemed Healthcare by 50.9% during the second quarter. Renaissance Technologies LLC now owns 438,700 shares of the company’s stock worth $2,873,000 after purchasing an additional 147,900 shares during the period. 74.24% of the stock is owned by hedge funds and other institutional investors.

About Viemed Healthcare

(Get Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

Recommended Stories